- Marfan's syndrome - Lupus Medication Number of number of patient-months In-center patients who receive < 7 Reconciliation for for which for all patients permanently hemodialysis treatments in the Patients Receiving medication assigned to a dialysis facility facility during the reporting month. Care at Dialysis reconciliation was during the reporting period. As detailed in Step 2” “Denominator Facilities performed and DENOMINATOR STEP 1. Identify above, transient patients, defined as documented by an all in-center and home in-center patients who receive < 7 eligible professional hemodialysis and peritoneal hemodialysis during the reporting dialysis patients permanently treatments in the facility during the period. assigned to the reporting month, are excluded from The medication dialysis facility in the given the measure. reconciliation MUST: calculation month. - Include the name or DENOMINATOR STEP 2. For all other unique identifier patients included in the of the eligible denominator in the given professional; calculation month in AND Step 1”, “Denominator - Include the date of the identify and remove all in-center reconciliation; hemodialysis patients who AND received < 7 dialysis treatments - Address ALL known in the calculation month. home medications DENOMINATOR STEP 3. Repeat (prescriptions, Step 1” and “Denominator herbals, Step 2” for each “Denominator vitamin/mineral/dietary month of the one-year reporting (nutritional) period. supplements, and medical marijuana); AND - Address for EACH home medication: Medication name(1), indication(2), dosage(2), frequency(2), route of administration(2), start and end date (if
- Marfan's syndrome - Lupus Medication Reconciliation for Patients Receiving Care at Dialysis Facilities Number of for which medication reconciliation was performed and documented by an eligible professional during the reporting period. The medication reconciliation MUST: - Include the name or other unique identifier of the eligible professional; AND - Include the date of the reconciliation; AND - Address ALL known home medications (prescriptions, herbals, vitamin/mineral/dietary (nutritional) supplements, and medical marijuana); AND - Address for EACH home medication: Medication name(1), indication(2), dosage(2), frequency(2), route of administration(2), start and end date (if number of patient-months for all patients permanently assigned to a dialysis facility during the reporting period. DENOMINATOR STEP 1. Identify all in-center and home hemodialysis and peritoneal dialysis patients permanently assigned to the dialysis facility in the given calculation month. DENOMINATOR STEP 2. For all patients included in the denominator in the given calculation month in “Denominator Step 1”, identify and remove all in-center hemodialysis patients who received < 7 dialysis treatments in the calculation month. DENOMINATOR STEP 3. Repeat “Denominator Step 1” and “Denominator Step 2” for each month of the one-year reporting period. In-center patients who receive < 7 hemodialysis treatments in the facility during the reporting month. As detailed in “Denominator Step 2” above, transient patients, defined as in-center patients who receive < 7 hemodialysis treatments in the facility during the reporting month, are excluded from the measure.